SYK Stryker Corporation

310.00USD-0.98%Mkt Cap: 118.01B USDP/E: 33.01

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segm…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap118.01B USD
Enterprise Value131.35B USD
Revenue (TTM)26.30B USD
Gross Profit16.07B USD
Net Income (TTM)3.25B USD
Revenue/Share68.70 USD
Last Price310.00 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees56.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)33.01
P/E (Forward)19.03
PEG1.53
EV/EBITDA17.49
EV/Revenue4.99
P/S4.49
P/B5.03
EPS (TTM)9.39 USD
EPS (Forward)16.29 USD
52W Range
267.0035% of range389.33
52W High389.33 USD
52W Low267.00 USD
Profitability
Gross Margin63.96%
Oper. Margin23.97%
EBITDA Margin28.56%
Profit Margin12.92%
ROE14.48%
ROA6.78%
ROIC10.64%
ROCE12.63%
Growth
Revenue Growth7.60%
Earnings Growth-11.70%
Cash Flow & Leverage
Operating CF5.04B USD
CapEx (TTM)761.00M USD
FCF Margin14.08%
FCF Yield3.14%
Net Debt12.16B USD
Net Debt/EBITDA1.62
Net Debt/FCF3.29
Balance Sheet
Debt/Equity0.71
Current Ratio2.18
Quick Ratio1.07
Book Value/Sh61.62 USD
Cash/Share8.59 USD
Dividends
Fwd Div Rate3.52 USD
Trail. Div Rate3.52 USD
Div. Yield1.12%
5Y Avg Yield0.99%
Payout Ratio37.49%
Ex-Div DateSep 30, 2026
Pay DateOct 30, 2026
Splits
Last Split2:1
Split DateMay 17, 2004
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)341.48 USD
Upside (mean)+10.2%
Target Range275.00 USD – 410.00 USD
275.00+10.2% to mean410.00
# Analysts27
Ownership
Shares Out.380.69M
Float345.82M
Insiders5.46%
Institutions82.55%
Short Interest
Short Ratio2.5d
Short % Float1.83%
Short % Out.1.75%
Shares Short6.66M
Short (prev mo.)5.74M
Technical
SMA 50294.08 (+5.4%)
SMA 200321.17 (-3.5%)
Beta0.77
S&P 52W Chg12.00%
Avg Vol (30d)2.95M
Avg Vol (10d)3.27M
Technical Indicators
RSI (14)50.1
MACD4.2783
MACD Signal6.0739
MACD Hist.-1.7956
BB Upper337.42 USD
BB Middle314.67 USD
BB Lower291.92 USD
BB Width14.46%
ATR (14)10.38 USD
Vol Ratio (20d)0.73x

About Stryker (NYSE: SYK)

›

Stryker (NYSE: SYK) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 56,000 employees.

The shares were at 310.00 USD on 20 November 2026, down 13.3% over 52 weeks. Its 52-week range is 267.00 USD to 389.33 USD: the price is 20.4% below the high and 16.1% above the low.

At a market capitalisation of 118.01B USD, it trades at 33.0 times trailing earnings and 19.0 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 24.9, a premium of 33% for SYK. It pays a dividend yielding 1.12% (it pays out 37% of its earnings), against a median of 2.43% among the dividend payers in that peer group.

Stryker reports return on equity of 14.5%, an operating margin of 24.0% and revenue up 7.6% year over year.

Its debt exceeds its cash by 12.16B USD, a debt-to-equity ratio of 0.71. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 27 analysts cover the stock, with an average rating of Buy; their mean price target of 341.48 USD is 10.2% above the current price. The next earnings report is expected on 28 January 2027.